NASDAQ:AVTX | EBITDA Margin | Avalo Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2025-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2025-12-31-33433.90%
2024-12-31-6897.40%
2023-12-31-1333.63%
2023-03-31-1844.00%
2022-12-31-984.38%
2022-03-31-1772.04%
2021-12-31-8067.58%
2021-03-31-6369.77%
2020-12-31-1055.51%
2020-03-31-1124.18%
2019-12-31-879.05%
2019-03-31-151.63%
2018-12-315.33%
2018-03-31-60.93%
2017-12-31-176.79%
2017-03-31-493046.61%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-123018.64%
2024-12-31-15497.28%
2023-12-31-1413.36%
2022-12-31-206.49%
2021-12-31-1490.87%
2020-12-31-1059.86%
2019-12-31-181.53%
2018-12-31-438.56%
2017-12-3151.47%
2016-12-31-1392.31%